glp-1 mimic Medication for Weight Loss: What You Need to Know Primer: The Skinny on GLP-1s

Government action adding additional pricing uncertainty As new drugs and indications reshape the clinical landscape, policymakers are reshaping cost and coverage frameworks

How soon will I see results

10.1016/j.febslet.2008.07.044 34

Study Data and Methods Cohort Identification We used the FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) 15 and product labels from Drugs@FDA 16 to identify all GLP-1 receptor agonists approved from 2005-2021 (see eMethods)

Submit today

GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda), along with tirzepatide (Zepbound), are FDA-approved medications for chronic weight management that work by regulating appetite and metabolism